Literature DB >> 16436681

Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3.

Xian Wu Cheng1, Masafumi Kuzuya, Kae Nakamura, Qun Di, Zexuan Liu, Takeshi Sasaki, Shigeru Kanda, Hai Jin, Guo-Ping Shi, Toyoaki Murohara, Mitsuhiro Yokota, Akihisa Iguchi.   

Abstract

Smooth muscle cell (SMC) migration from the tunica media to the intima, a key event in neointimal formation, requires proteolytic degradation of elastin-rich extracellular matrix barriers. Although cathepsin S (Cat S) is overexpressed in atherosclerotic and neointimal lesions, its exact role in SMC behavior remains primarily unresolved. We examined the involvement of Cat S on SMC migration through an extracellular matrix barrier and its localization in SMCs. A selective Cat S inhibitor and the endogenous inhibitor cystatin C significantly attenuated SMC invasion across elastin gel. Western blotting and cell surface biotinylation analysis demonstrated localization of the 28-kd active form of Cat S on the SMC surface, consistent with its role in the proteolysis of subcellular matrices. Treatment with interferon-gamma or interleukin-beta1 significantly augmented the ability of SMC membranes to degrade elastin along with a significant increase in the level of active Cat S compared with controls. Immunofluorescence and confocal microscopy showed a punctuated pattern of Cat S clusters at the periphery of SMCs; further studies demonstrated partial co-localization of Cat S and integrin alphanubeta3 at the cell surfaces. These findings demonstrate that active Cat S co-localizes with integrin alphanubeta3 as a receptor on the SMC surface, playing an important role in the invasive behavior of SMCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436681      PMCID: PMC1606490          DOI: 10.2353/ajpath.2006.050295

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  MMP-2 colocalizes with caveolae on the surface of endothelial cells.

Authors:  A Puyraimond; R Fridman; M Lemesle; B Arbeille; S Menashi
Journal:  Exp Cell Res       Date:  2001-01-01       Impact factor: 3.905

2.  MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells.

Authors:  E I Deryugina; B Ratnikov; E Monosov; T I Postnova; R DiScipio; J W Smith; A Y Strongin
Journal:  Exp Cell Res       Date:  2001-02-15       Impact factor: 3.905

3.  Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells.

Authors:  M Watari; H Watari; M E DiSanto; S Chacko; G P Shi; J F Strauss
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.

Authors:  S M Ellerbroek; D A Fishman; A S Kearns; L M Bafetti; M S Stack
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

5.  Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice.

Authors:  S Kanda; M Kuzuya; M A Ramos; T Koike; K Yoshino; S Ikeda; A Iguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

6.  Structural basis for different inhibitory specificities of human cystatins C and D.

Authors:  A Hall; I Ekiel; R W Mason; F Kasprzykowski; A Grubb; M Abrahamson
Journal:  Biochemistry       Date:  1998-03-24       Impact factor: 3.162

7.  Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

Authors:  P C Brooks; S Strömblad; L C Sanders; T L von Schalscha; R T Aimes; W G Stetler-Stevenson; J P Quigley; D A Cheresh
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

8.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.

Authors:  G K Sukhova; G P Shi; D I Simon; H A Chapman; P Libby
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

9.  Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.

Authors:  A Punturieri; S Filippov; E Allen; I Caras; R Murray; V Reddy; S J Weiss
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  20 in total

1.  Histopathological analysis of cellular localization of cathepsins in abdominal aortic aneurysm wall.

Authors:  Fabian Lohoefer; Christian Reeps; Christina Lipp; Martina Rudelius; Alexander Zimmermann; Stefan Ockert; Hans-Henning Eckstein; Jaroslav Pelisek
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

Review 2.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

Review 3.  Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.

Authors:  Yanwen Qin; Guo-Ping Shi
Journal:  Pharmacol Ther       Date:  2011-05-12       Impact factor: 12.310

4.  Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.

Authors:  Xian Wu Cheng; Toyoaki Murohara; Masafumi Kuzuya; Hideo Izawa; Takeshi Sasaki; Koji Obata; Kohzo Nagata; Takao Nishizawa; Masakazu Kobayashi; Takashi Yamada; Weon Kim; Kohji Sato; Guo-Ping Shi; Kenji Okumura; Mitsuhiro Yokota
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

5.  Cathepsin K activity controls injury-related vascular repair in mice.

Authors:  Lina Hu; Xian Wu Cheng; Haizhen Song; Aiko Inoue; Haiying Jiang; Xiang Li; Guo-Ping Shi; Eiji Kozawa; Kenji Okumura; Masafumi Kuzuya
Journal:  Hypertension       Date:  2013-12-16       Impact factor: 10.190

6.  Mechanism of diastolic stiffening of the failing myocardium and its prevention by angiotensin receptor and calcium channel blockers.

Authors:  Xian Wu Cheng; Kenji Okumura; Masafumi Kuzuya; Zhehu Jin; Kohzo Nagata; Koji Obata; Aiko Inoue; Akihiro Hirashiki; Kyosuke Takeshita; Kazumasa Unno; Ken Harada; Guo-Ping Shi; Mitsuhiro Yokota; Toyoaki Murohara
Journal:  J Cardiovasc Pharmacol       Date:  2009-07       Impact factor: 3.105

7.  Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.

Authors:  Xiang Li; Zexuan Liu; Zeen Cheng; Xianwu Cheng
Journal:  Chonnam Med J       Date:  2012-08-24

8.  Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy.

Authors:  Xin Li; Hang Zhu; Peng Li; Qian Xin; Jie Liu; Wei Zhang; You-Hong Xing; Hao Xue
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

9.  Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.

Authors:  Masaya Fujita; Xian W Cheng; Yasuya Inden; Masayuki Shimano; Naoki Yoshida; Aiko Inoue; Toshihiko Yamamoto; Kyosuke Takeshita; Seifuku Kyo; Noriko Taguchi; Guo-Ping Shi; Masafumi Kuzuya; Kenji Okumura; Toyoaki Murohara
Journal:  J Am Heart Assoc       Date:  2013-12-16       Impact factor: 5.501

10.  Remodeling of aorta extracellular matrix as a result of transient high oxygen exposure in newborn rats: implication for arterial rigidity and hypertension risk.

Authors:  Fanny Huyard; Catherine Yzydorczyk; Michele M Castro; Anik Cloutier; Mariane Bertagnolli; Hervé Sartelet; Nathalie Germain; Blandine Comte; Richard Schulz; Denis DeBlois; Anne Monique Nuyt
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.